About EMTHERAPRO INC
Emtherapro is a company focused on transforming the diagnosis and treatment of neurodegenerative diseases through next-generation precision medicine, offering solutions that integrate proteomics, AI, and systems biology to accelerate drug discovery and clinical trials.
Generation of high-resolution data from proteomics and other omics platformsExtensive reference database on neurodegenerative diseasesMarket leading clinical, scientific, and analytical expertiseAdvanced ML, AI, and Systems Biology capabilitiesPrecision proteomics for biofluids and tissuesDrug discovery and validation supportClinical trials optimization including biomarker identification and participant screening
Is this your company?
Claim EMTHERAPRO INC to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim EMTHERAPRO INC & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.